{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:56:48Z","timestamp":1777618608979,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Galway University Hospital Perinatal Fund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejphar.2016.07.025","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T22:21:51Z","timestamp":1468707711000},"page":"328-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["In vitro contractile effects of agents used in the clinical management of postpartum haemorrhage"],"prefix":"10.1016","volume":"789","author":[{"given":"John J.","family":"Morrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis J.","family":"Crankshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.07.025_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/molehr\/gah158","article-title":"Identification and localization of prostaglandin E2 receptors in upper and lower segment human myometrium during pregnancy","volume":"11","author":"Astle","year":"2005","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.ejphar.2016.07.025_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s12630-014-0190-1","article-title":"Comparative efficacy of uterotonic agents: in vitro contractions in isolated myometrial strips of labouring and non-labouring women","author":"Balki","year":"2014","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.ejphar.2016.07.025_bib3","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1213\/ANE.0000000000000682","article-title":"The contractile effects of oxytocin, ergonovine, and carboprost and their combinations: an in vitro study on human myometrial strips","volume":"120","author":"Balki","year":"2015","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2016.07.025_bib4","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1213\/ANE.0b013e3181d74898","article-title":"The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries","volume":"110","author":"Bateman","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2016.07.025_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00404-013-3016-4","article-title":"Medical prevention and treatment of postpartum hemorrhage: a comparison of different guidelines","volume":"289","author":"Bohlmann","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ejphar.2016.07.025_bib6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bpobgyn.2008.08.004","article-title":"Epidemiology of postpartum haemorrhage: a systematic review","volume":"22","author":"Carroli","year":"2008","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.ejphar.2016.07.025_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bjp.0703072","article-title":"Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells","volume":"129","author":"Chan","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.07.025_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/ALN.0000000000000940","article-title":"In vitro comparative effect of carbetocin and oxytocin in pregnant human myometrium with and without oxytocin pretreatment","volume":"124","author":"Cole","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2016.07.025_bib9","doi-asserted-by":"crossref","first-page":"155.e1","DOI":"10.1016\/j.ajog.2011.03.014","article-title":"Methodology and pharmacological analysis of effects of uterotonic compounds in human myometrium in vitro","volume":"205","author":"Crankshaw","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2016.07.025_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/1933719115572483","article-title":"Maternal age and contractility of human myometrium in pregnancy","volume":"22","author":"Crankshaw","year":"2015","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ejphar.2016.07.025_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejphar.2014.05.037","article-title":"The influence of smooth muscle content and orientation in dissected human pregnant myometrial strips on contractility measurements","volume":"738","author":"Crankshaw","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.07.025_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(98)00513-5","article-title":"Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation","volume":"355","author":"Engstr\u00f8m","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.07.025_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajog.2012.07.034","article-title":"Postpartum hemorrhage in the developed world: whither misoprostol?","volume":"208","author":"Gibbins","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2016.07.025_bib14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/1933719112468951","article-title":"Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review","volume":"20","author":"Gizzo","year":"2013","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ejphar.2016.07.025_bib15","first-page":"CD003249","article-title":"Treatment for primary postpartum haemorrhage","volume":"2","author":"Mousa","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2016.07.025_bib16","unstructured":"Royal College of Obstetricians & Gynaecologists, 2009. Postpartum haemorrhage, prevention and Management (Green-Top Guideline No. 52). (retrieved 06.07.2015)."},{"key":"10.1016\/j.ejphar.2016.07.025_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1476-5381.1993.tb12832.x","article-title":"In vitro characterization of prostanoid receptors on human myometrium at term pregnancy","volume":"108","author":"Senior","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.07.025_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ajog.2014.07.012","article-title":"Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety","volume":"212","author":"Shields","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2016.07.025_bib19","first-page":"528","article-title":"Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, in nonpregnant women","volume":"47","author":"Sweeney","year":"1990","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.ejphar.2016.07.025_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2014.11.026","article-title":"Off-label use of misoprostol for labor induction in Germany: a national survey","volume":"187","author":"Voigt","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ejphar.2016.07.025_bib21","unstructured":"World Health Organization, 2012. WHO recommendations for the prevention and treatment of postpartum haemorrhage. (retrieved 06.07.15)."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916304654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916304654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T13:11:36Z","timestamp":1617455496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916304654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":21,"alternative-id":["S0014299916304654"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.07.025","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro contractile effects of agents used in the clinical management of postpartum haemorrhage","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}